Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
SSY GROUP Signs LOI on Potential Co-op for Two Class 2 Chemically Modified New Drugs
Recommend 2 Positive 1 Negative 0 |
||||
|
||||
|
SSY GROUP (02005.HK) announced that a wholly-owned subsidiary of the Company entered into a letter of intent (LOI) with Xinzheng Heying in relation to a possible collaboration in respect of two class 2 modified new drugs of chemical drug, being a class 2.2 antispasmodic drug for children; and a class 2.3 drug targeting chronic obstructive pulmonary diseases. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
